Pasithea Therapeutics Corp. (KTTAW)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-37.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $486.6K | $15.1K | — |
| Cost of Revenue | — | — | — | $113.2K | $17.3K | — |
| Gross Profit | — | — | — | — | -$2.2K | — |
| Operating Income | -$20.86M | -$14.25M | -$15.98M | -$12.59M | -$4.51M | — |
| Net Income | -$20.43M | -$13.90M | -$15.96M | -$13.94M | -$2.17M | — |
| EPS (Diluted) | $-2.91 | $-12.69 | $-0.42 | $-1.76 | $-0.21 | — |
| Total Assets | $60.24M | $16.06M | $26.12M | $45.18M | $53.32M | $248.0K |
| Total Liabilities | $5.02M | $1.28M | $2.72M | $2.68M | $1.90M | $6.6K |
| Shareholders' Equity | $55.22M | $14.78M | $23.40M | $42.50M | $51.42M | $241.4K |
| Cash & Equivalents | $55.16M | $6.92M | $16.33M | $33.09M | $52.97M | $243.7K |
| Operating Cash Flow | -$15.21M | -$13.92M | — | -$14.56M | -$3.17M | — |
| Capital Expenditures | — | — | $34.3K | $107.1K | $21.5K | — |
| Shares Outstanding | 23.09M | 1.39M | 1.04M | 1.30M | 23.01M | 7.47M |